PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
Clinical trial NCT03283943 · UNKNOWN
Trial details
- NCT number
- NCT03283943
- Sponsor
- British Columbia Cancer Agency
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2020-12-16
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.